Anzeige
Mehr »
Login
Freitag, 04.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Ist das der Durchbruch für den KI-Biotech-Geheimtipp?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU8Q | ISIN: CA74141E1043 | Ticker-Symbol: 18H
Frankfurt
04.04.25
08:00 Uhr
0,010 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PREVECEUTICAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
PREVECEUTICAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0050,02116:25

Aktuelle News zur PREVECEUTICAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoPreveceutical Medical Inc: Preveceutical increases private placement to $500,0002
PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln
DoPreveCeutical Medical Inc.: PreveCeutical Announces Update to Non-Brokered Private Placement371Vancouver, British Columbia--(Newsfile Corp. - April 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered...
► Artikel lesen
11.03.Preveceutical Medical Inc: Preveceutical Medical extends private placement4
10.03.PreveCeutical Medical Inc.: PreveCeutical Announces Update to Private Placement462Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its news...
► Artikel lesen
06.02.PreveCeutical Medical Inc.: PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease281Vancouver, British Columbia--(Newsfile Corp. - February 6, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces a program aiming to...
► Artikel lesen
04.02.Preveceutical Medical Inc: Preveceutical appoints Jones to lead Sol-Gel projects3
04.02.PreveCeutical Medical Inc.: Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects191Vancouver, British Columbia--(Newsfile Corp. - February 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), (the "Company" or "PreveCeutical") a health sciences company that...
► Artikel lesen
24.01.PreveCeutical Medical Inc.: PreveCeutical Announces Non-Brokered Private Placement839Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered...
► Artikel lesen
07.01.PreveCeutical Medical Inc.: BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference492Vancouver, British Columbia--(Newsfile Corp. - January 7, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
18.12.24PreveCeutical Medical Inc.: PreveCeutical Announces Change of Auditors418Vancouver, British Columbia--(Newsfile Corp. - December 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that the Company has...
► Artikel lesen
09.12.24Preveceutical Medical Inc: Preveceutical's BioGene appoints Lawson as director6
09.12.24PreveCeutical Medical Inc.: BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors423Vancouver, British Columbia--(Newsfile Corp. - December 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
05.12.24Preveceutical Medical Inc: Preveceutical's BioGene adds Ticho to advisory board5
05.12.24PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho846Vancouver, British Columbia--(Newsfile Corp. - December 5, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
04.12.24Preveceutical Medical Inc: Preveceutical's BioGene appoints advisory board member3
04.12.24PreveCeutical Medical Inc.: BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board301Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
02.12.24Preveceutical Medical Inc: Preveceutical unit appoints Glover independent director2
02.12.24PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Stephen Glover to Its Board of Directors236Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
25.11.24Preveceutical Medical Inc: Preveceutical's BioGene appoints Sampath as director1
25.11.24PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors273Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
Seite:  Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1